Afferent Pharmaceuticals, Inc. — Form D
Afferent Pharmaceuticals, Inc. of San Mateo, CA, a company, filed a Form D exempt-offering notice with the SEC on 2015-07-14. The offering totals $55.0M, of which $55.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2015-07-14
- Form: D
- Accession: 0001140361-15-027467
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $55.0M
- Amount sold: $55.0M
- Investors: 17
- Date of first sale: 2015-07-01
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-243651
Issuer
- Name: Afferent Pharmaceuticals, Inc.
- CIK: 0001476010
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2009
- Address: 2929 Campus Drive, Suite 230, San Mateo, CA, 94403
- Phone: 650-286-1276
Officers, directors & promoters (16)
| Name | Role | Location |
|---|
| Kathleen Sereda Glaub | Director | San Carlos, CA |
| Peter Sereda Hirth | Director | San Diego, CA |
| Arthur Sereda Pappas | Director | San Mateo, CA |
| Liam Sereda Ratcliffe | Director | San Mateo, CA |
| Kevin Sereda Starr | Director | San Mateo, CA |
| Jesse Sereda Treu | Director | San Mateo, CA |
| Anthony Sereda Ford | Executive Officer | San Mateo, CA |
| Kathleen Sereda Glaub | Executive Officer | San Carlos, CA |
| Michael Sereda Kitt | Executive Officer | San Mateo, CA |
| David Neafus | Executive Officer | Walpole, MA |
| Mitchell S Bloom | Executive Officer | New York, NY |
| Kevin Starr | Director | Cambridge, MA |
| Kevin Starr | Executive Officer | Cambridge, MA |
| Arthur S Pappas | Director | Monmouth Junction, NJ |
| Liam S Ratcliffe | Director | New York, NY |
| Jesse S Treu | Director | Princeton, NJ |
Other filings by this issuer (2)
More